Abstract
The role of lymph node dissection (LND) in the staging and treatment of renal cell carcinoma has long been a topic of debate. The controversy has focused on whether LND is purely an adjunctive staging procedure or has a therapeutic role in the management of this disease. Potential benefits include enhanced staging, better selection for adjuvant therapies/clinical trials, a decrease in recurrence rates, and improved disease-specific and overall survival. This article reviews the available literature on LND in renal cell carcinoma and discusses the potential benefits of aggressive surgical resection in select high-risk patients.
Original language | English (US) |
---|---|
Pages (from-to) | 419-428 |
Number of pages | 10 |
Journal | Urologic Clinics of North America |
Volume | 38 |
Issue number | 4 |
DOIs | |
State | Published - Nov 2011 |
Keywords
- Lymph node dissection
- Lymphadenectomy
- Renal cell carcinoma
- Staging
- Therapeutic
ASJC Scopus subject areas
- Urology